Jeffrey Stein - 18 Aug 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
President & CEO, Director
Signature
/s/ Jeffrey Stein
Issuer symbol
CDTX
Transactions as of
18 Aug 2021
Net transactions value
+$86,755
Form type
4
Filing time
19 Aug 2021, 16:24:31 UTC
Previous filing
16 Jun 2021
Next filing
15 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Purchase $68,884 +40,000 +11% $1.72 405,878 18 Aug 2021 Direct F1, F2
transaction CDTX Common Stock Purchase $17,871 +10,000 +2.5% $1.79 415,878 19 Aug 2021 Direct F3
holding CDTX Common Stock 231,602 18 Aug 2021 by trust
holding CDTX Common Stock 42,009 18 Aug 2021 by son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6990 to $1.7300, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F2 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2021.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7850 to $1.7899, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.